Article Figures & Data
Tables
Items Group I Group II Group III Statistic Cases 24 22 21 Course of disease (days) 11.7±6.2 45.9±16.4 388.1±267.3 Gender Male 6 6 10 X2=2.63 p=0.27 Female 18 15 11 F=1.65 p=0.20 Age (years) 67.0±9.0 70.2±8.7 71.4±7.1 F=0.127 p=0.881 BMI (kg/m2) 21.8±1.2 21.8±1.2 22.0±1.1 Affected sites Neck, shoulder and upper limbs 6 4 6 X2=1.15 p=0.89 Chest, back and abdomen 10 12 9 Waist and lower limbs 8 6 6 VAS 7.3±0.9 7.0±0.9 6.9±0.7 F=1.64 p=0.20 QS 0.8±0.7 0.7±0.7 1.0±0.6 F=0.63 p=0.54 BMI - body mass index, QS - quality of sleep, VAS - visual analog scale
Groups Cases Before treatment At 1 day after treatment At 3 months after treatment At 6 months after treatment I 24 7.3±0.9 2.5±1.1*,† 1.8±1.2*,†,†† 1.3±1.3*,†,††,‡ II 22 7.0±0.9 2.8±1.0*,† 3.2±0.9*,**,† 3.1±0.9*,**,† III 21 6.9±0.7 4.7±0.7† 4.5±0.5† 4.6±0.6† *- p<0.05, compared with group III at the same time point; ** - p<0.05, compared with group I at the same time point; † - indicates the comparison within the group relative to the pretreatment value; †† - indicates the comparison within the group relative to the value at 1 day after treatment; ‡ - indicates the comparison within the group relative to the value at 3 months after treatment. VAS - visual analog scale
Groups Cases Before treatment At 1 day after treatment At 3 months after treatment At 6 months after treatment I 24 0.8±0.7 3.1±0.7*,† 3.3±0.6*,† 3.4±0.6*,† II 22 0.7±0.7 3.1±0.5*,† 2.9±0.6*,**,† 3.0±0.7*,**† III 21 1.0±0.6 1.8±0.5† 1.9±0.5† 1.9±0.5† * - p<0.05, compared with group I at the same time point; ** - p<0.05, compared with group III at the same time point. † - indicates the comparison within the same group relative to the value before treatment, p<0.0083. QS - quality of sleep
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.